Eosinophil cationic protein and clinical outcome after bare metal stent implantation

Atherosclerosis

Volumn 215, Issue 1, 2011, Pages 166-169

  Niccoli, Giampaolo ^a   Sgueglia, Gregory A ^a   Conte, Micaela ^a   Cosentino, Nicola ^a   Minelli, Silvia ^a   Belloni, Flavia ^a   Trani, Carlo ^a   Sabato, Vito ^a   Burzotta, Francesco ^a   Porto, Italo ^a   Leone, Antonio Maria ^a   Schiavino, Domenico ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Bare metal stents; Eosinophil cationic protein; Eosinophils; Prognosis

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN;

ACUTE CORONARY SYNDROME; AGED; ALLERGIC REACTION; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART INFARCTION; HUMAN; IMPLANTATION; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVASCULARIZATION; STABLE ANGINA PECTORIS;

AGED; EOSINOPHIL CATIONIC PROTEIN; FEMALE; HUMANS; MALE; STENTS; TREATMENT OUTCOME;

EID: 79952103751     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.11.044     Document Type: Article

References (16)

1. Garg S., Serruys P.W. Coronary stents: current status. J Am Coll Cardiol 2010, 56(10):S1-42.
2. Niccoli G., Schiavino D., Belloni F., et al. Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents. Eur Heart J 2009, 30:1340-1347.
3. Virmani R., Guagliumi G., Farb A., et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?. Circulation 2004, 109:701-705.
4. Rittersma S.Z., Meuwissen M., van der Loos C.M., et al. Eosinophilic infiltration in restenotic tissue following coronary stent implantation. Atherosclerosis 2006, 184:157-162.
5. Koster R., Vieluf D., Kiehn M., et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 2000, 356:1895-1897.
6. Zavalloni D., Bossi P., Rossi M.L., et al. Inflammatory substrate with eosinophils may be present in bare-metal stent thrombosis. J Cardiovasc Med 2009, 10:942-943.
7. Bassand J.P., Hamm C.W., Ardissino D., et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007, 28:1598-1660.
8. LeBlanc M., Crowley J. Relative risk trees for censored survival data. Biometrics 1992, 48:411-425.
9. Venge P. Monitoring the allergic inflammation. Allergy 2004, 59:26-32.
10. Budinger L., Hertl M. Immunologic mechanisms in hypersensitivity reactions to metal ions: an overview. Allergy 2000, 55:108-115.
11. Nakatani M., Takeyama Y., Shibata M., et al. Mechanisms of restenosis after coronary intervention: difference between plain old balloon angioplasty and stenting. Cardiovasc Pathol 2003, 12:40-48.
12. Samoszuk M., Corwin M., Hazen S.L. Effects of human mast cell tryptase and eosinophil granule proteins on the kinetics of blood clotting. Am J Hematol 2003, 73:18-25.
13. Rittersma S.Z., van der Wal A.C., de Winter R.J. Eosinophilic tissue response several weeks after sirolimus-eluting Cypher stent implantation within a bare metal stent in a coronary saphenous vein graft. Catheter Cardiovasc Interv 2006, 67:38-40.
14. Moqbel R., Lacy P. Molecular mechanisms in eosinophil activation. Chem Immunol 2000, 78:189-198.
15. Hoshida S., Nishino M., Takeda T., et al. A persistent increase in C-reactive protein is a risk factor for restenosis in patients with stable angina who are not receiving statins. Atherosclerosis 2004, 173:285-290.
16. Burzotta F., Trani C., Todaro D., et al. Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: results of the SKICE (Skylor in real world practice) registry. Catheter Cardiovasc Interv 2009, 73:457-465.